PE20030287A1 - Composiciones farmaceuticas de terbinafina - Google Patents
Composiciones farmaceuticas de terbinafinaInfo
- Publication number
- PE20030287A1 PE20030287A1 PE2002000645A PE2002000645A PE20030287A1 PE 20030287 A1 PE20030287 A1 PE 20030287A1 PE 2002000645 A PE2002000645 A PE 2002000645A PE 2002000645 A PE2002000645 A PE 2002000645A PE 20030287 A1 PE20030287 A1 PE 20030287A1
- Authority
- PE
- Peru
- Prior art keywords
- sodium
- magnesium stearate
- coating
- microcrystalline cellulose
- colloidal silica
- Prior art date
Links
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical group C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title abstract 4
- 229960002722 terbinafine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 5
- 235000019359 magnesium stearate Nutrition 0.000 abstract 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 239000008119 colloidal silica Substances 0.000 abstract 3
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 3
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008213 purified water Substances 0.000 abstract 2
- 239000011734 sodium Substances 0.000 abstract 2
- 229910052708 sodium Inorganic materials 0.000 abstract 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 2
- 229960000699 terbinafine hydrochloride Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229920003134 Eudragit® polymer Polymers 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 abstract 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 230000000181 anti-adherent effect Effects 0.000 abstract 1
- 239000003911 antiadherent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000001012 protector Effects 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 abstract 1
- 229940080313 sodium starch Drugs 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 229940032147 starch Drugs 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0117760A GB0117760D0 (en) | 2001-07-20 | 2001-07-20 | Organic compounds |
| GB0128993A GB0128993D0 (en) | 2001-12-04 | 2001-12-04 | Organic compounds |
| GB0212209A GB0212209D0 (en) | 2002-05-27 | 2002-05-27 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030287A1 true PE20030287A1 (es) | 2003-05-06 |
Family
ID=27256227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000645A PE20030287A1 (es) | 2001-07-20 | 2002-07-22 | Composiciones farmaceuticas de terbinafina |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20040198838A1 (enExample) |
| EP (1) | EP1411921B2 (enExample) |
| JP (3) | JP2005503399A (enExample) |
| KR (2) | KR100699958B1 (enExample) |
| CN (1) | CN100358518C (enExample) |
| AR (1) | AR034813A1 (enExample) |
| AT (1) | ATE381329T1 (enExample) |
| AU (1) | AU2002321249B2 (enExample) |
| BR (1) | BR0211198A (enExample) |
| CA (1) | CA2453263C (enExample) |
| CY (1) | CY1107861T1 (enExample) |
| DE (1) | DE60224194T3 (enExample) |
| DK (1) | DK1411921T4 (enExample) |
| ES (1) | ES2295381T5 (enExample) |
| HU (1) | HUP0401200A3 (enExample) |
| IL (2) | IL159591A0 (enExample) |
| MX (1) | MXPA04000627A (enExample) |
| MY (1) | MY136136A (enExample) |
| NO (1) | NO332268B1 (enExample) |
| NZ (1) | NZ530648A (enExample) |
| PE (1) | PE20030287A1 (enExample) |
| PL (1) | PL365416A1 (enExample) |
| PT (1) | PT1411921E (enExample) |
| RU (1) | RU2298402C2 (enExample) |
| SI (1) | SI1411921T2 (enExample) |
| TW (1) | TWI302460B (enExample) |
| WO (1) | WO2003022267A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| AU2003244633A1 (en) * | 2002-07-02 | 2004-01-23 | Novartis Ag | Methods for the treatment of sinusitis |
| JP2005060310A (ja) * | 2003-08-13 | 2005-03-10 | Towa Yakuhin Kk | 不快な味をマスキングする経口投与用製剤 |
| JP2005187339A (ja) * | 2003-12-24 | 2005-07-14 | Iwaki Seiyaku Co Ltd | 耐光性塩酸テルビナフィンフィルムコート錠 |
| JP4999297B2 (ja) * | 2005-08-10 | 2012-08-15 | 高田製薬株式会社 | 高含量塩酸テルビナフィン小型錠剤 |
| WO2007110753A2 (en) * | 2006-03-28 | 2007-10-04 | Wockhardt Ltd | Extended release dosage forms of metoprolol |
| CN1820744B (zh) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 磷酸奥司他韦颗粒剂及其制备方法 |
| CA2648495C (en) * | 2006-04-26 | 2016-07-05 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
| EP2029113A2 (en) * | 2006-06-07 | 2009-03-04 | Novartis AG | Process for making multiparticulates using a roller compactor |
| MX2011007779A (es) * | 2009-01-28 | 2011-08-12 | Novartis Ag | Formulaciones galenicas de compuestos organicos. |
| WO2010086732A1 (en) * | 2009-01-30 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Stable compositions for nail and skin treatment |
| CN102198111A (zh) * | 2011-06-17 | 2011-09-28 | 哈尔滨乐泰药业有限公司 | 一种抗真菌药物片剂的制备方法 |
| WO2013043143A1 (ru) * | 2011-09-21 | 2013-03-28 | Slyusar Viktor Timopheevich | Способ снижения лишнего веса |
| US10071058B2 (en) * | 2012-03-07 | 2018-09-11 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
| IL296490B1 (en) * | 2016-03-15 | 2025-09-01 | Acer Therapeutics Inc | Tasty compositions containing sodium phenylbutyrate and their uses |
| WO2018069388A1 (en) | 2016-10-11 | 2018-04-19 | Khalifa University of Science and Technology | Coated chloride salt particles and methods of making and using the same |
| FR3069545B1 (fr) * | 2017-07-27 | 2020-10-16 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage exempte de dioxyde de titane |
| CN109833301A (zh) * | 2017-11-29 | 2019-06-04 | 天津市保灵动物保健品有限公司 | 一种犬猫用盐酸特比萘芬风味片及其制备工艺 |
| CN109925296B (zh) * | 2017-12-19 | 2021-09-07 | 四川济生堂药业有限公司 | 一种中药微丸的包衣方法 |
| CN112156078A (zh) * | 2020-11-11 | 2021-01-01 | 乐泰药业有限公司 | 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法 |
| US20220175812A1 (en) | 2020-12-03 | 2022-06-09 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| CN115869273B (zh) * | 2022-10-31 | 2025-09-30 | 修正药业集团长春高新制药有限公司 | 一种盐酸特比萘芬片及其制备方法 |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK62184D0 (da) † | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| DE3572440D1 (en) * | 1984-06-19 | 1989-09-28 | Basf Ag | Gastro-resistant cylindrical pancreatine-microtablets |
| US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| US4894375A (en) * | 1986-09-29 | 1990-01-16 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
| RU2033991C1 (ru) * | 1989-06-08 | 1995-04-30 | Ф.Хоффманн-Ля Рош Аг | Производные аминоалкилбензола или их фармацевтически приемлемые соли с кислотами |
| DE3937455A1 (de) * | 1989-11-10 | 1991-05-16 | Nordmark Arzneimittel Gmbh | Antacidatabletten |
| GB9111477D0 (en) * | 1991-05-29 | 1991-07-17 | Sandoz Ltd | Pharmaceutical composition |
| US5262172A (en) * | 1992-06-19 | 1993-11-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing buffered bile acids |
| US5415872A (en) * | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| US5578304A (en) * | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| US5332727A (en) * | 1993-04-29 | 1994-07-26 | Birkmayer U.S.A. | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
| WO1995016465A1 (en) * | 1993-12-14 | 1995-06-22 | Sandoz Ltd. | Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates |
| GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
| FR2722102B1 (fr) * | 1994-07-11 | 1996-08-23 | Cird Galderma | Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses |
| NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
| FR2751878B1 (fr) * | 1996-07-30 | 1998-09-04 | Oreal | Utilisation dans une composition d'un extrait d'au moins une labiee |
| US5814230A (en) * | 1996-08-30 | 1998-09-29 | Willis; H. Craig | Apparatus and method for separation of solids from liquid |
| DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
| FR2755011B1 (fr) * | 1996-10-31 | 1998-11-20 | Cird Galderma | Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v. |
| CN1244119A (zh) * | 1997-01-06 | 2000-02-09 | 辉瑞大药厂 | 迅速释放和掩蔽味觉的药物剂型 |
| US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| FR2771291B1 (fr) † | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
| DE19842753A1 (de) † | 1998-09-18 | 2000-03-23 | Bayer Ag | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| US20010055613A1 (en) * | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
| EP2260836B1 (en) * | 1998-11-25 | 2016-08-10 | Cima Labs Inc. | Rapid release tablet with coated drug-containing core and surrounding taste masking layer |
| US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
| NZ513037A (en) † | 1999-01-29 | 2003-05-30 | Disphar Internat B | Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract |
| US6248363B1 (en) † | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| CN1116033C (zh) * | 1999-07-08 | 2003-07-30 | 齐鲁制药厂 | 一种治疗阴道炎的泡腾片剂及其制法 |
| JP2003506480A (ja) * | 1999-08-17 | 2003-02-18 | ノバルテイス・コンシユーマー・ヘルス・エス・アー | 急速に溶解する剤形およびその製造方法 |
| GB0001315D0 (en) * | 2000-01-20 | 2000-03-08 | Novartis Ag | Organic compounds |
| WO2001062229A1 (en) † | 2000-02-24 | 2001-08-30 | Advanced Pharma, Inc. | Therapeutic product, use and formulation thereof |
| DE10017996A1 (de) * | 2000-04-11 | 2001-10-18 | Pierre Foss | Lamisil-Intervall-System |
| GB0014448D0 (en) * | 2000-06-13 | 2000-08-09 | Novartis Ag | Organic compounds |
| AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| WO2004069157A2 (en) * | 2003-01-17 | 2004-08-19 | Ophthalmic Research Associates, Inc. | Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
-
2002
- 2002-07-18 AR ARP020102698A patent/AR034813A1/es unknown
- 2002-07-19 BR BR0211198-5A patent/BR0211198A/pt not_active IP Right Cessation
- 2002-07-19 SI SI200230669T patent/SI1411921T2/sl unknown
- 2002-07-19 PL PL02365416A patent/PL365416A1/xx not_active Application Discontinuation
- 2002-07-19 US US10/483,436 patent/US20040198838A1/en not_active Abandoned
- 2002-07-19 WO PCT/EP2002/008095 patent/WO2003022267A1/en not_active Ceased
- 2002-07-19 ES ES02754918T patent/ES2295381T5/es not_active Expired - Lifetime
- 2002-07-19 CN CNB028141040A patent/CN100358518C/zh not_active Expired - Fee Related
- 2002-07-19 DK DK02754918.7T patent/DK1411921T4/da active
- 2002-07-19 JP JP2003526396A patent/JP2005503399A/ja not_active Withdrawn
- 2002-07-19 EP EP02754918A patent/EP1411921B2/en not_active Expired - Lifetime
- 2002-07-19 KR KR1020067011980A patent/KR100699958B1/ko not_active Expired - Fee Related
- 2002-07-19 HU HU0401200A patent/HUP0401200A3/hu unknown
- 2002-07-19 AT AT02754918T patent/ATE381329T1/de active
- 2002-07-19 AU AU2002321249A patent/AU2002321249B2/en not_active Ceased
- 2002-07-19 IL IL15959102A patent/IL159591A0/xx unknown
- 2002-07-19 PT PT02754918T patent/PT1411921E/pt unknown
- 2002-07-19 KR KR1020047000865A patent/KR100651110B1/ko not_active Expired - Fee Related
- 2002-07-19 MX MXPA04000627A patent/MXPA04000627A/es active IP Right Grant
- 2002-07-19 NZ NZ530648A patent/NZ530648A/en not_active IP Right Cessation
- 2002-07-19 CA CA2453263A patent/CA2453263C/en not_active Expired - Fee Related
- 2002-07-19 TW TW091116154A patent/TWI302460B/zh not_active IP Right Cessation
- 2002-07-19 MY MYPI20022738A patent/MY136136A/en unknown
- 2002-07-19 DE DE60224194T patent/DE60224194T3/de not_active Expired - Lifetime
- 2002-07-19 RU RU2004105263/15A patent/RU2298402C2/ru not_active IP Right Cessation
- 2002-07-22 PE PE2002000645A patent/PE20030287A1/es not_active Application Discontinuation
-
2003
- 2003-12-25 IL IL159591A patent/IL159591A/en not_active IP Right Cessation
-
2004
- 2004-01-19 NO NO20040254A patent/NO332268B1/no not_active IP Right Cessation
-
2008
- 2008-01-18 CY CY20081100079T patent/CY1107861T1/el unknown
- 2008-06-17 JP JP2008158153A patent/JP2008280351A/ja active Pending
- 2008-07-18 US US12/218,806 patent/US20080286356A1/en not_active Abandoned
-
2012
- 2012-02-01 JP JP2012020039A patent/JP2012136523A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030287A1 (es) | Composiciones farmaceuticas de terbinafina | |
| CA2082944C (en) | Pharmaceutical compositions | |
| ES2358896T3 (es) | Composiciones farmacéuticas que comprenden un analgésico opioide. | |
| JO2555B1 (en) | Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent | |
| TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
| BR0213948A (pt) | Forma de dosagem de liberação controlada dual | |
| CA2315261A1 (en) | Oral pharmaceutical extended release dosage form | |
| CO5560580A2 (es) | Formulaciones de sucralosa para disumular sabores desagradables | |
| RU2000131897A (ru) | Пероральная дозировочная композиция пролонгированного действия | |
| ES2571703T3 (es) | Formulaciones de oxicodona de una vez al día | |
| UY24288A1 (es) | Procedimiento para la preparación de una composición de liberación retardada de paroxetina | |
| IT1245891B (it) | Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. | |
| HUP0401569A2 (hu) | Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra | |
| UY25234A1 (es) | Formulación de liberación prolongada de venlafaxina | |
| KR850700212A (ko) | 서방성 약제학적 캼셀제 | |
| KR950031052A (ko) | 알푸조신 히드로클로라이드의 서방성 투약형태 | |
| AR036658A1 (es) | Formulacion de dosificacion oral de fundicion instantanea | |
| BR0111868A (pt) | Composições farmacêuticas | |
| BR0212155A (pt) | Composição farmacêutica | |
| ATE361743T1 (de) | Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung | |
| SE0102440D0 (sv) | New compound | |
| RU2008151945A (ru) | Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина | |
| PE20010568A1 (es) | Formulaciones orales de liberacion controlada | |
| ECSP003508A (es) | Formas polimorfas de un citrato de azobiciclo [2.2.2] octan-3-amina y sus composiciones farmaceuticas | |
| CA2413775A1 (en) | A combination kit used in the treatment of malaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |